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ducible measurements) were included in the analysis of air-
flow limitation.  Results:  A total of 29,817 spirometries were 
analyzed. Quality grades A–D and F were assigned to 33.9, 
7.1, 19.4, 27.8 and 11.8% of spirometries, respectively. 95% 
required  ^  5 trials to achieve spirometries assigned grade A. 
The prevalence of mild, moderate, severe and very severe 
airway obstruction in individuals with spirometries graded 
A–C was 6, 15, 5 and 1%, respectively.  Conclusion: Spirom-
etries in general practice are of acceptable quality with re-
producible spirometry in 60% of measurements. Airway ob-
struction was found in 27% of current smokers aged  6 40 
years. Office spirometry provides a simple and quick means 
of detecting airflow limitation, allowing earlier diagnosis 
and intervention in many patients with early COPD. 
 Copyright © 2009 S. Karger AG, Basel 
 Introduction 
 Chronic obstructive pulmonary disease (COPD) is a 
leading cause of morbidity and mortality worldwide  [1] 
and is predicted to be the third leading cause of death 
worldwide by 2020  [2] . Smoking is the leading cause of 
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 Abstract 
 Background: Diagnosis of chronic obstructive pulmonary 
disease (COPD) and its severity determination is based on 
spirometry. The quality of spirometry is crucial.  Objectives: 
Our aim was to assess the quality of spirometry performed 
using a spirometer with automated feedback and quality 
control in a general practice setting in Switzerland and to 
determine the prevalence of airflow limitation in smokers 
aged  6 40 years.  Method: Current smokers  6 40 years of age 
were consecutively recruited for spirometry testing by gen-
eral practitioners. General practitioners received spirometry 
training and were provided with an EasyOne TM spirometer. 
Spirometry tests were assigned a quality grade from A to D 
and F, based on the criteria of the National Lung Health Edu-
cation Program. Only spirometry tests graded A–C (repro-
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COPD and there is good evidence that smoking cessation 
may influence the progression of COPD  [3–5] . However, 
evidence suggests that awareness of COPD in potential 
sufferers is insufficient to impact on smoking behavior 
 [6] . Screening for airflow limitation in smokers, there-
fore, may be beneficial, in particular in those attempting 
to quit smoking  [7, 8] . Recent studies indicate that smok-
ers attending smoking cessation counseling programs 
with spirometrically identified airway obstruction have 
slightly higher cessation rates compared with those with 
a normal spirometry  [9, 10] . These differences in quit 
rates become more pronounced in subgroups of smokers 
with moderate or severe airway obstruction  [9, 10] .
 In primary care, COPD is under- and misdiagnosed 
 [11] and a questionnaire-based medical history is inferior 
to spirometry for the identification of patients with COPD 
 [12] . Based on the Global Initiative for Chronic Obstruc-
tive Lung Disease (GOLD) guidelines  [13] , COPD is de-
fined as airway obstruction that is not fully reversible, and 
thus spirometry is needed to identify COPD. In one study 
of office-based spirometry, over 30% of patients diag-
nosed with COPD in primary care were found to have 
normal spirometries, when tested in a pulmonary func-
tion laboratory  [11] . Spirometry is technically demanding 
and also, depending on the devices chosen, calibration 
prior to the tests is needed. Further, the test is dependent 
on the patients’ cooperation  [14] . In a study to assess the 
impact of training during a spirometry workshop, only 
33.1% of spirometries performed by trained primary care 
providers and 12.5% performed by control group partici-
pants achieved the requirement of at least 2 acceptable 
spirometry maneuvers that were in accordance with qual-
ity criteria as defined by the American Thoracic Society 
(ATS)  [15] . However, this may be more symptomatic of 
spirometry in general rather than indicative of the quality 
of technicians in primary care. Schermer et al .  [16] re-
ported a small but statistically significant difference in 
lung function values between spirometry performed in 
general practice and in a pulmonary function laboratory. 
In terms of reproducibility, though, the quality of spirom-
etry did not differ significantly between the 2 settings.
 In recent years, new devices with automated feedback 
mechanisms and quality control measurement to simpli-
fy the procedure for the investigator have become avail-
able for use in primary care. The quality control and feed-
back algorithms in such devices have been standardized 
in a consensus statement from the National Lung Health 
Education Program (NLHEP)  [17] .
 We conducted a study to evaluate the quality of spiro-
metric measurements by spirometers with automated 
feedback and quality control in primary care in Switzer-
land. Further, we wanted to determine the prevalence of 
airflow limitation in smoking patients aged  6 40 years 
consulting general practices.
 Methods 
 A total of 440 out of 1,800 general practitioners (GPs) taken 
from a Swiss physicians’ register (maintained by the Swiss Medi-
cal Association, FMH) agreed to participate in the study in re-
sponse to a one-off bulk mailing of invitation letters. No specific 
recruitment criteria for participating GPs were used. The Easy-
One TM spirometer (ndd Medizintechnik AG, Zurich, Switzerland) 
with disposable mouthpieces was provided without charge to the 
participating physicians. Before commencing the study, partici-
pating physicians and their practice nurses were instructed on 
how to perform spirometry according to ATS guidelines by rep-
resentatives of the spirometry sales company  [18] . This instruc-
tion took place at the physician’s office and took approximately 
1–2 h. They were taught how to operate the spirometer and how 
to perform the spirometry test. In addition to theoretical instruc-
tion, all participants were examined on their practical ability ac-
cording to ATS guidelines  [18] . Physicians were asked to recruit 
at least 60 current smokers aged  6 40 years, independently of the 
reason for consultation. For simplicity, inclusion was limited to 
current smokers only. There were no data collected on previous 
spirometries or confirmed diagnoses. The study was approved by 
the institutional Ethics Committee.
 In this study, we used a spirometer with ultrasonic transit-
time flow measurement technology with built-in software for 
quality control and feedback for the examiner. The EasyOne spi-
rometer is factory calibrated and, due to its operating principle, 
does not need further calibration  [19] . All spirometry measure-
ments were performed in a seated position and required the use 
of a nose clip. The quality of spirometry was assessed automati-
cally by the spirometer, as suggested in the consensus statement 
from the NLHEP  [17] , using the grading recommended from that 
report. The spirometry data were classified in quality control 
(QC) grades A–D and F ( table 1 ). A mean QC grade was assigned 
to spirometry data using the criteria of Ferguson et al.  [17] .
 The built-in feedback mode gives instructions that are dis-
played on the screen of the device as follows:
 – ‘don’t hesitate’: back-extrapolated volume  1 150 ml or  1 5%, 
whichever is greater 
 – ‘blast out faster’: time until peak flow  1 120 ms 
 – ‘blow out longer’: expiration time  ! 2 s or volume during last 
0.5 s  1 100 ml when expiration time is  ! 6 s  
 – ‘good effort, do next’: test meets the above-mentioned criteria 
 – ‘blast out harder’: peak flow not reproducible; difference with 
respect to best test  1 1.0 liters/s 
 – ‘deeper breath’: forced expiratory volume in 1 s (FEV 1 ) or 
forced vital capacity (FVC) not reproducible; difference with 
respect to best test  1 150 ml 
 – ‘test complete’: 3 acceptable tests, FEV 1 and FVC within 
200/250 ml (after 5 trials) 
 For the assessment of the prevalence of airway obstructions in 
smoking patients, we considered only spirometries with quality 
grades A–C. Quality grades A–C ask for a reproducibility of at 
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least 250 ml. For the predicted values, we used the reference values 
by Brandli et al.  [20] (Swiss study on Air Pollution and Lung Dis-
eases in Adults). Interpretation of the spirometry data was per-
formed by the authors according to the criteria of the GOLD com-
mittee, Hardie et al. and Fabbri et al.  [1, 21, 22] , with the exception 
that prebronchodilator data was used. Therefore, airway obstruc-
tion was defined as having a prebronchodilator FEV 1 /FVC  ! 70% 
in patients younger than 70 years of age, FEV 1 /FVC  ! 65% in pa-
tients between 70 and 80 years of age and  ! 60% in patients older 
than 80 years of age. Possible restriction was assigned if FEV 1 /
FVC  1 lower limit of normal (LLN), FVC  ! LLN and FEV 1  ! 
LLN.
 Statistical Analyses 
 Continuous variables are expressed as means (with standard 
deviations in parentheses), and categorical variables are expressed 
as relative frequencies and percentages. Analysis was performed 
with use of SPSS version 12 and Microsoft  Excel 2003 software.
 Results 
 Patients 
 A total number of 440 GPs participated in this study. 
The mean number of spirometry tests done by each GP 
was 67. In total, 30,991 tests were performed. After deleting 
repeated tests in the same patient (the spirometries with 
the lower quality grades were deleted), 29,817 tests were 
available for analysis of the quality of the spirometry.
 Quality of Spirometry 
 Of the spirometry tests included in the analysis, the 
distribution according to the quality grades was as fol-
lows: grade A, 10,104 (33.9%); grade B, 2,115 (7.1%); grade 
C, 5,778 (19.4%); grade D, 8,295 (27.8%); grade F, 3,525 
(11.8%).
 The quality of spirometric data was influenced by total 
number of tests performed ( fig. 1 ). GPs who performed 
fewer than 10 tests had the lowest mean quality scores. 
The mean QC grade increased notably in GPs with more 
than 10 tests and was highest in GPs with 21–30 tests. 
Quality did not continue to improve in GPs with  1 30 tests 
and was actually lower in GPs with 71–100 tests com-
pared with GPs with 11–70 tests. Overall, 95% of the sub-
jects with QC grade A achieved the results with less than 
5 trials ( fig. 2 ).
Table 1. Criteria for QC grading of spirometry measurements 
[17]
QC grade Criteria
A At least 3 acceptable tests AND the difference
between the best 2 FEV1 and FVC values is
≤150 ml
B At least 3 acceptable tests AND the difference
between the best 2 FEV1 and FVC values is
≤200 ml
C At least 2 acceptable tests AND the difference
between the best 2 FEV1 and FVC values is
≤250 ml
D At least 2 acceptable trials but the results are not
reproducible
Quality message: ‘result not reproducible’ OR only
one acceptable trial
Quality message: ‘only one acceptable trial’
F No acceptable test available
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 Fig. 1. Mean QC grades of spirometry 
measurements according to the number of 
spirometries performed by each GP (n = 
29,817). 
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 Prevalence of Airflow Limitation 
 A total of 4,822 spirometries from subjects younger 
than 40 years of age were deleted for the analysis of air-
flow limitation; thus, the sample consisted of 24,995 spi-
rometries in smokers aged 40 and above. Their mean age 
was 51.6 years; 58.6% were male and 41.4% were female. 
Using the reference values from Brandli et al.  [20] airway 
obstruction was found in 27% of patients ( table 2 ). Mild 
(6%) and moderate (15%) airflow obstruction were col-
lectively more commonly detected than severe (5%) and 
very severe (1%) airflow obstruction. Possible airflow re-
striction was detected in 15% of the study population ( ta-
ble 2 ).
 Discussion 
 The present study evaluated the quality of spirometry 
data obtained in a general practice setting using a hand-
held spirometer equipped with automated feedback and 
QC. We found that in excess of 60% of spirometry tests 
performed were acceptable in terms of quality. From 
these data, we determined that the prevalence of airflow 
limitation in Swiss smokers aged  6 40 years is 27%.
 The consensus statement from the NLHEP recom-
mends that office spirometry should be performed in all 
patients  6 45 years, patients presenting with respiratory 
symptoms and patients desiring a health assessment  [17] . 
Such a recommendation is dependent on spirometry per-
formed in general practice being of sufficient quality to 
allow the accurate diagnosis, treatment and monitoring 
of patients with COPD. The current study demonstrates 
that good-quality spirometry is achievable using a spi-
rometer equipped with automated feedback and QC. 
More than half of the spirometry tests included in our 
analysis were assigned a quality grade A–C.
 The key strengths of our study are the large number of 
patients (especially considering the estimated 7.6 million 
population of Switzerland), the general practice setting 
and the standardized use of the same type of spirometer. 
Compromises were necessary, however, and notable 
weaknesses include consecutive, nonrandomized data 
collection, nonrandomized selection of GPs, absence of a 
comparator group as well as absence of data on pre-exist-
ing, known airway obstruction and other diseases. Since 
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 Fig. 2. Number of trials needed to achieve 
a certain quality grade (n = 29,817). 
Table 2. Diagnosis of airflow obstruction in smokers aged ≥40 
when applying the reference values by Brandli et al. [20]
Measurements Acceptable tests, %
Total measurements 24,995
Unclassified 9,911
Quality grade A–C 15,084 100
Normal spirometry 8,533 57
Mild obstruction 951 6
Moderate obstruction 2,217 15
Severe obstruction 818 5
Very severe obstruction 245 2
Possible restriction 2,320 15
Unclassified: Quality grades D and F.
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completing this study, the criteria for quality grades have 
been revised  [23] .
 Our results indicate the existence of a training effect 
in that the lowest mean quality grade was assigned to GPs 
who had performed fewer than 10 tests. The mean qual-
ity increased with the number of tests performed, reach-
ing a peak in GPs who had performed 21–30 tests. There-
after, the mean quality was lower, suggesting that both 
initial training and refresher training may be important 
in maintaining high standards of spirometry. The benefit 
of refresher training is illustrated by the results of the 
Burden of Obstructive Lung Disease study  [24] . In this 
study, which also used the EasyOne spirometer, only 4% 
of patients were excluded from the analysis due to unus-
able spirometry data. The quality of spirometry was con-
tinuously monitored and, if quality levels dropped below 
a certain predefined threshold, the technician perform-
ing spirometry was required to be retrained and recerti-
fied before continuing. The lack of correlation between 
experience and quality, over and above the initial train-
ing effect observed in the current study, reaffirms the 
suggestion that refresher training is central to maintain-
ing high standards of spirometry. Although poor spirom-
etry is often attributed to error or lack of coaching on the 
part of the investigator, good spirometry also requires a 
degree of cooperation and effort from the patient. This 
study did not investigate what proportion of poor-quality 
spirometry was due to a lack of cooperation from the pa-
tient. 
 The NLHEP consensus statement also stipulates that 
the automated feedback and QC mechanisms of spirom-
eters, such as the one used in this study, should permit 
 1 90% of patients to meet the required QC threshold in 
fewer than 5 trials. The results of this study suggest that 
this stipulation was not achieved. Nevertheless, the qual-
ity of the spirometry performed here is higher than in a 
previous study  [15] . In a prospective, randomized con-
trolled trial, fully acceptable and reproducible tests were 
only achieved in 13.5% of patient tests in the trained GP 
group and in 3.4% of the control GP group  [15] . In our 
primary care environment, 95, 91 and 87% of tests graded 
A, B and C, respectively, were achieved in 5 or fewer tri-
als, suggesting that the use of the EasyOne spirometer 
came close to achieving the stipulated  1 90% success 
rate.
 The prevalence of airflow limitation in our population 
of Swiss smokers aged  6 40 years was 27%. A mild to 
moderate airway obstruction was found in 21% and a se-
vere to very severe airway obstruction in 6%. The preva-
lence of airflow limitation observed in this study concurs 
with that reported in similar studies. Zieliñski et al.  [8] 
observed airflow limitation in 41% of Polish smokers 
aged  6 40 years and van Schayck et al.  [7] reported that 
18% of Dutch smokers aged 35–70 years had an FEV 1 of 
 ! 80% predicted.
 The use of spirometry in general practice is not uni-
versally supported due to the risk of misdiagnosis and the 
risk that smoking behavior may be reinforced in those 
smokers found to have normal lung during spirometry 
testing  [25] . However, taking into account that recent 
published trials suggest that early intervention may mod-
ify the clinical course of the disease  [26, 27] , early detec-
tion of COPD could be important.
 The cost of spirometers remains one of the most sig-
nificant barriers to the widespread use of spirometry in 
primary care. However, it is probable that office spirom-
eters will not be prohibitively expensive in the future and 
that spirometry in general practice will become more 
commonplace. The price of office spirometers has de-
creased in recent years, and this trend is likely to con-
tinue.
 In summary, spirometric screening for patients with a 
high risk for COPD in general practice using a spirometer 
with automated feedback frequently fulfills the criteria of 
spirometry in a pulmonary function laboratory. Further-
more, office spirometry provides a simple and quick 
means of detecting airflow limitation. Though this would 
need to be confirmed in a specialist laboratory, screening 
in this way would allow earlier diagnosis and interven-
tion in many patients with early COPD.
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